
ECI Biotech, based in Worcester, US, is a leading developer and producer of rapid infection detection sensors.
ECI Biotech, headquartered in Worcester, US, is a pioneering company specializing in the development and production of innovative, patented sensors for rapid infection detection, known as ExpressDetect. The company's core mission is to enhance healthcare outcomes through early and accurate detection of infections, thereby reducing treatment times and improving patient care. ECI Biotech's vision is to revolutionize the medical diagnostics market by providing reliable, quick, and cost-effective solutions that can be easily integrated into existing healthcare systems.
Notable figures associated with ECI Biotech include its team of experienced scientists and engineers who have contributed significantly to the field of biosensors. The company has garnered attention from key investors in the biotech industry, bolstering its research and development efforts. ECI Biotech's achievements include several patents for their sensor technology and successful clinical trials demonstrating the efficacy of their products. The overall impact of ECI Biotech lies in its potential to transform infection management practices, ultimately leading to better patient outcomes and more efficient healthcare delivery.
Companies similar to ECI Biotech include Innovative Biosensors, PhageTech, HeMemics Biotechnologies and OmniVis.
ECI Biotech was founded in 1998.
ECI Biotech's headquarters is located in Worcester, MA, US.
ECI Biotech's most recent funding round was for $500k (USD) in January 2010.
As of Jan 26, 2010, ECI Biotech has disclosed funding of $3.4M (USD). Undisclosed round amounts are excluded.
ECI Biotech has 30 employees as of Feb 4, 2024.
OmniVis
omnivistech.com